Lv1
40 积分 2024-01-05 加入
Proteolysis-targeting chimera (PROTAC) nanomedicines toward cancer treatment: From synthesis to therapeutic delivery
1个月前
已完结
Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape
1个月前
已完结
Expanding the ligand spaces for E3 ligases for the design of protein degraders
1个月前
已完结
Trivalent PROTACs enhance protein degradation via combined avidity and cooperativity
1个月前
已完结
Research progress of deubiquitinating enzymes in cerebral ischemia-reperfusion injury
1个月前
已关闭
Protein Modifications with Ubiquitin as Response to Cerebral Ischemia-Reperfusion Injury
1个月前
已完结
Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity
1个月前
已完结
Progress in the controllability technology of PROTAC
2个月前
已完结
PROTAC technology: From drug development to probe technology for target deconvolution
2个月前
已完结
Aptamer-Mediated Covalent Dual Lysosome-Targeting Chimeras Enhance Targeted Degradation of Cell Surface Proteins
3个月前
已关闭
皖公网安备34019202002308
